|
|
Pharmaceutical Companies Market Research Reports
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Pharmaceutical Companies, including, but not limited to: Profile; R&D Strategy; Company Directory; Drug Directory.
We offer market research, industry forecasts, and business analysis in the Pharmaceutical Companies as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| Les Laboratoires Servier: PharmaVitae Profile |
|
| Table of Contents Published: 2009/11 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Servier in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s ... |
| Pharmaceutical Industry in Mexico |
|
| Table of Contents Published: 2009/11 Published by: Aruvians Rsearch |
| Over the past decade, pharmaceutical companies have pushed the scientific envelope, working at the cellular and molecular levels to dramatically advance the treatment of disease. ... |
| King Pharmaceuticals Inc.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/11 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for King in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale ... |
| Pharmaceutical Mergers and Acquisitions |
|
| Table of Contents Published: 2009/10 Published by: Cutting Edge Information |
| Pharmaceutical Mergers and Acquisitions guides you to build an M&A plan that focuses on key goals, avoids costly mistakes, and realizes deal potential as quickly as possible. CEI designed this study to identify the primary drivers of M&A activity. Through ... |
| Competitor Analysis: Coagulation Factors |
|
| Table of Contents Published: 2009/10 Published by: La Merie |
| The present Competitive Intelligence Report about Coagulation Factors provides a competitor evaluation in the field of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or acquired coagulation di ... |
| Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile |
|
| Table of Contents Published: 2009/10 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| Allergan Inc.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/10 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Allergan in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fore ... |
| Drug Delivery Partnering Agreements in Pharma and Biotech |
|
| Table of Contents Published: 2009/10 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Drug Delivery Partnering Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading healthcare companies. ... |
| AstraZeneca: Pipeline, Products, Performance, Potential |
|
| Table of Contents Published: 2009/10 Published by: Espicom Business Intelligence |
| AstraZeneca has corporate headquarters in London, and research and development headquarters in Sweden. It focuses on a number of therapeutic areas: gastrointestinal, respiratory, cardiovascular, pain control/anaesthesia, central nervous system, oncology a ... |
| Boston Scientific Medical Device Company Intelligence Report |
|
| Table of Contents Published: 2009/10 Published by: Espicom Business Intelligence |
| Boston Scientific, headquartered in Natick, Massachusetts, USA, develops and manufactures products for use in minimally-invasive procedures. The company's products are offered for sale by two dedicated business groups - Cardiovascular and Endosurgery. ... |
| Bristol-Myers Squibb Co.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/09 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for BMS in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales ... |
| Abbott Laboratories: PharmaVitae Profile |
|
| Table of Contents Published: 2009/09 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Abbott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| AstraZeneca plc: PharmaVitae Profile |
|
| Table of Contents Published: 2009/09 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for AstraZeneca in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ... |
| Gilead Sciences Inc.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/09 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Gilead in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| Novo Nordisk A/S: PharmaVitae Profile |
|
| Table of Contents Published: 2009/09 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Novo Nordisk in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales ... |
| The Recession and its Impact on Pharmaceutical M&A Activity |
|
| Table of Contents Published: 2009/09 Published by: Espicom Business Intelligence |
| Mergers and, more commonly, acquisitions have long been popular in the pharmaceutical industry. Whether it has been to support flagging drug pipelines, secure IP on promising drug candidates or to quickly access new markets, the industry has for many year ... |
| Competitor Analysis: EGF-R Agonists and Antagonists |
|
| Table of Contents Published: 2009/09 Published by: La Merie |
| The present Competitive Intelligence Report about EGF-R agonists and antagonists provides a competitor evaluation in the field of epidermal growth factor receptor (EGF-R; ErbB1) targeting molecules for wound healing or treatment of cancer as of September ... |
| Partnering Agreements in Diagnostics |
|
| Table of Contents Published: 2009/09 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Partnering Agreements in Diagnostics report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and ... |
|
| International Pharmaceutical Agreement (IPA) |
|
| Issues / Year: 12 Published by: Espicom Business Intelligence |
| It may be a company sponsoring original research with a university, a technology transfer deal for gene screening, or a licensing agreement to commercially exploit sales in a country or region. ... |
| PharmaDeals Review |
|
| Published by: PharmaVentures Ltd |
| The new PharmaDeals Review does all of that. PharmaDeals Review is the only rapid communications publication that delivers instant, relevant articles and analyses on deal making and industry issues, and examines their impact on deals. ... |
|
|
|
View Cart
